Bioqual Company Description
Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States.
The company provides contract research services in the areas of AIDS, influenza, respiratory syncytial virus, Coronavirus, malaria, hepatitis, cancer, and other infectious diseases, as well as flavivirus infections, including zika and dengue.
It also offers small and large animal models. In addition, the company provides cell-based assays, immunoassay, toxicology and cytotoxicity testing, viral load testing, and tailored assay development services; and Biocontainment, imaging services, and animal model development; and IND-enabling services, such as toxicology studies, pharmacokinetic profiling, GLP services, and regulatory documentation services.
Bioqual, Inc. was incorporated in 1981 and is based in Rockville, Maryland.
| Country | United States |
| Founded | 1981 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 113 |
| CEO | Mark Lewis |
Contact Details
Address: 9620 Medical Center Drive Rockville, Maryland 20850 United States | |
| Phone | 240 404 7654 |
| Website | bioqual.com |
Stock Details
| Ticker Symbol | BIOQ |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | June - May |
| Reporting Currency | USD |
| ISIN Number | US09065J1016 |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Dr. Hanne Andersen-Elyard Ph.D. | President and Chief Scientific Officer |
| Charles C. Kirk Jr., CPA | Chief Financial Officer |
| Mitchell L. Franklin | Chief Operating Officer and Secretary |